“One Health”

Recent epidemics such as those caused by the Sars-CoV-2, Influenza A, Ebola and Zika viruses have shown that the solutions implemented to control them are generally too late to be fully effective. The latest epizootics such as highly pathogenic avian influenza, the emergence and worrying inter-species transmission of multiresistant bacteria to antibiotics further confirm the need to develop a more proactive and holistic approach to the prevention of health crises according to the concept “One Health”. Such an approach presents significant opportunities for reducing the impact of emergence or re-emergence events of infectious diseases, natural or induced.

In this context, BforCure is revolutionizing bio-detection technologies with the ultimate goal of making our planet a safer place, protecting us against global threats. To do so, the company designs, manufactures, and commercializes innovative ultra-fast and sensitive PCR biosensing solutions.
Recognized and supported by key innovation players, the company develops technological platforms through an ambitious R&D program, challenging the state of the art in biodetection methods. Microfluidics technology is at the heart of BforCure products, which serve in various fields such as medical diagnostics, defense and security, industry, food industry, and environmental protection.